57 related articles for article (PubMed ID: 21626284)
1. Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
Jinnouchi T; Yoshimoto M; Ogino K; Oji T; Hayashi M
Intern Med; 2024 May; 63(10):1399-1404. PubMed ID: 37779064
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithium-induced multiple endocrinopathy.
Kamath C; Govindan J; Premawardhana AD; Wood SJ; Adlan MA; Premawardhana LD
Clin Med (Lond); 2013 Aug; 13(4):407-10. PubMed ID: 23908517
[TBL] [Abstract][Full Text] [Related]
3. A lesson for the clinical nephrologist: desmopressin and its unforeseen efficacy in clinical post-obstructive diuresis.
Been RA; Voets PJGM; van Rhijn-Brouwer FCC; Vogtländer NPJ
J Nephrol; 2024 Mar; 37(2):515-517. PubMed ID: 37856066
[No Abstract] [Full Text] [Related]
4. The therapeutic effect of oral desmopressin lyophilisate formulation in children with central diabetes insipidus.
Korkmaz HA; Coşkunol F; Barışık V; Ozkan B
J Pediatr Endocrinol Metab; 2023 Oct; 36(10):925-929. PubMed ID: 37658767
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes Insipidus.
Pedersen AN; Andreassen M; Rasmussen AK; Krogh J
Horm Metab Res; 2024 Mar; 56(3):206-213. PubMed ID: 37879354
[TBL] [Abstract][Full Text] [Related]
6. Diabetes insipidus--diagnosis and management.
Di Iorgi N; Napoli F; Allegri AE; Olivieri I; Bertelli E; Gallizia A; Rossi A; Maghnie M
Horm Res Paediatr; 2012; 77(2):69-84. PubMed ID: 22433947
[TBL] [Abstract][Full Text] [Related]
7. National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.
Juul KV; Schroeder M; Rittig S; Nørgaard JP
J Clin Endocrinol Metab; 2014 Jun; 99(6):2181-7. PubMed ID: 24527719
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Management of Central Diabetes Insipidus in Adults.
Tomkins M; Lawless S; Martin-Grace J; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2022 Sep; 107(10):2701-2715. PubMed ID: 35771962
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.
Chin X; Teo SW; Lim ST; Ng YH; Han HC; Yap F
Eur J Clin Pharmacol; 2022 Jun; 78(6):907-917. PubMed ID: 35199198
[TBL] [Abstract][Full Text] [Related]
10. Management of Diabetes Insipidus following Surgery for Pituitary and Suprasellar Tumours.
Almalki MH; Ahmad MM; Brema I; Almehthel M; AlDahmani KM; Mahzari M; Beshyah SA
Sultan Qaboos Univ Med J; 2021 Aug; 21(3):354-364. PubMed ID: 34522399
[TBL] [Abstract][Full Text] [Related]
11. Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats.
Dahlgren D; Olander T; Sjöblom M; Hedeland M; Lennernäs H
Acta Pharm Sin B; 2021 Jun; 11(6):1667-1675. PubMed ID: 34221875
[TBL] [Abstract][Full Text] [Related]
12. Serum sodium and intracranial pressure changes after desmopressin therapy in severe traumatic brain injury patients: a multi-centre cohort study.
Harrois A; Anstey JR; Taccone FS; Udy AA; Citerio G; Duranteau J; Ichai C; Badenes R; Prowle JR; Ercole A; Oddo M; Schneider A; van der Jagt M; Wolf S; Helbok R; Nelson DW; Skrifvars MB; Cooper DJ; Bellomo R;
Ann Intensive Care; 2019 Sep; 9(1):99. PubMed ID: 31486921
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Insipidus after Traumatic Brain Injury.
Capatina C; Paluzzi A; Mitchell R; Karavitaki N
J Clin Med; 2015 Jul; 4(7):1448-62. PubMed ID: 26239685
[TBL] [Abstract][Full Text] [Related]
14. The evolutionary origin of the vasopressin/V2-type receptor/aquaporin axis and the urine-concentrating mechanism.
Juul KV
Endocrine; 2012 Aug; 42(1):63-8. PubMed ID: 22374125
[TBL] [Abstract][Full Text] [Related]
15. Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.
Juul KV; Bichet DG; Nørgaard JP
Endocrine; 2011 Aug; 40(1):67-74. PubMed ID: 21626284
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
17. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
18. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
